Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
228.5 USD | +0.16% | -3.07% | -3.53% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.53% | 11.75B | |
+23.28% | 44.96B | |
+0.40% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.92% | 26.08B | |
-21.03% | 19.03B | |
+6.34% | 12.75B | |
+29.11% | 12.06B | |
+20.52% | 11.72B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Wells Fargo Adjusts Charles River Laboratories International Price Target to $275 From $280, Maintains Overweight Rating